论文部分内容阅读
随着老年人口的增多,肺癌发病率近年来逐渐增高,是恶性肿瘤中居首位的死亡原因,其中非小细胞肺癌占所有肺癌病例的75%～80%大多数肺癌诊断时多为中晚期,患者已经失去手术治疗的最佳机会,手术治疗效果较差,这样,以化疗为主的综合治疗中就成为治疗晚期肺癌的重要手段之一,随着现代影像技术的应用和介入器械的发展,支气管动脉化疗药物灌注术联合中心静脉置管化疗已成为支气管肺癌综合治疗的重要治疗,使近期疗效得到了明显的改善。我院2006年以来对51例IV期NSCLC进行了支气管动脉灌注化疗加中心静脉置管化疗,效果较好,报道如下。
With the increase of the elderly population, the incidence of lung cancer gradually increased in recent years, is the leading cause of death in malignant tumors, of which non-small cell lung cancer accounts for 75% to 80% of all lung cancer most of the diagnosis of lung cancer mostly in the advanced stage, patients Has lost the best chance of surgical treatment, surgical treatment less effective, so that chemotherapy-based comprehensive treatment has become an important means of treatment of advanced lung cancer, with the application of modern imaging technology and the development of interventional devices, bronchus Arterial chemotherapy drug infusion combined with central venous catheterization chemotherapy has become an important treatment of bronchial lung cancer comprehensive treatment, so that the recent treatment has been significantly improved. 51 cases of stage IV NSCLC in our hospital since 2006, bronchial artery infusion chemotherapy plus central venous catheter chemotherapy, the effect is better, reported as follows.